CLINICAL_TRIALS
trial_result
· 2018-10-30
Clinical Trial Update: Linagliptin Inpatient Trial [Phase 4]
Summary
Phase 4 inpatient trial of linagliptin for type 2 diabetes has completed, with results posted on 2018-10-30. The study was sponsored by Emory University.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2018-10-30